Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017
Fri, December 15, 2017
Thu, December 14, 2017
Wed, December 13, 2017
Tue, December 12, 2017
Mon, December 11, 2017
Fri, December 8, 2017
Thu, December 7, 2017
Wed, December 6, 2017
Tue, December 5, 2017
Mon, December 4, 2017
Fri, December 1, 2017
Thu, November 30, 2017
Wed, November 29, 2017
Tue, November 28, 2017
Mon, November 27, 2017
Wed, November 22, 2017
Tue, November 21, 2017
Mon, November 20, 2017
Fri, November 17, 2017
Thu, November 16, 2017

Matthew Luchini Initiated (BOLD) at Buy and Held Target at $35 on, Dec 5th, 2017


//stocks-investing.news-articles.net/content/201 .. t-buy-and-held-target-at-35-on-dec-5th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "Boundless Bio, Inc." (BOLD) at Buy and Held Target at $35 on, Dec 5th, 2017.

Matthew has made no other calls on BOLD in the last 4 months.



There are 4 other peers that have a rating on BOLD. Out of the 4 peers that are also analyzing BOLD, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, October 16th, 2017
  • Reni Benjamin of "Raymond James" Initiated at Hold on, Thursday, October 12th, 2017


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $35 on, Tuesday, October 17th, 2017
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $33 on, Friday, September 22nd, 2017

Publication Contributing Sources